Member Info for howdlep

Https://finance.yahoo.com/news/global-digital-biopsy-market-poised-170000032.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAADBNKsdS1mCWX4tCQa7UnlKJfWjXNImNqCYHU7B47GA9OGjs5LkgB6DPRl0Dg1fGdZ5rAf0Ii_xk_ld0gqh9SCkoLDOeYHRAtd6PrCIPySN0XLqd9VMqTjrZ2K9O9foUGraIAWtYxHogXMCivQKETVBN_0cyenV8NJ8qa_f9OF3j

Here is a question to which I presume the answer is no.

I have always thought a phase III trial would not be necessary. However, with phase I now 'soft closed', is there any possibility with substantially more 'world data' from the EAP, that a BTD could be granted, so alleviating the need for even a phase II?

I appreciate we would be limited by the maximum dosage tolerated in phase I, as the EAP is only a more accessible extension to phase 1.

Would this trial conclusion still be attractive to a buyer or is phase II a minimum?

Thoughts appreciated, as I am thinking ahead to Congress legislation and voucher applications .

As Paladin points out, "I find it difficult to believe that a serious investor, who had done their due diligence on the company, and its IP and other assets, would buy in at 1p, and sell at 4-5 months later at a 22-40% loss?"

My only consideration, if you read between the lines of the RNS'. is that IBAI could go it alone re phase II. Now as we have said many times, IBAI can't do a placing below the nominal value of shares which is 1p, without a GM. That said, I presume TB could issue CLN's at say 0.5p. Unfortunately, if he wanted to raise £2m for phase II (may need more) that would mean converting into 400m shares. That is a non starter re the massive dilution. However, if he did do that, I could see BRH wanting to sell their IBAI shares and replacing with CLN's at 50% of the price they originally invested at.

Of course, that would mean the BRH Board are privy to IBAI insider information. TB would not divulge any such information, as that would be a criminal offence.

Just rambling as usual.

Tyke,

You stated that "Interestingly according to the BRH results they class IBAI has having a book value of about £600k."

Let me just correct your wording if I may.

This means the book value of their investment in IBAI is £572,085 which at the time equates to a IBAI bid price of 0.79p.

((65,415,862 @ 1.1p) + (7,000,000 @ 1p)) = £789,000 (investment)

(£572,085 / 72,415,862) x 100 = 0.79p (bid price at the time of the results)

Since then, the bid price has dropped to 0.60p, meaning the book value has further reduced to £434k.

Phil

Tyke,

You regularly post this type of message. I suspect, like myself, you value your HL portfolio based on the bid, something that is a HL option.

We closed at 0.6/0.65p on Friday, so that would be reflected of the drop you mention. However, if you looked at a delayed quote on advfn or did a dummy HL quote for tiny, you would see the real spread is 0.60/0.67.

It's just annoying that HL haven't reset without any trades.

Also, as you know, some trade sites like investing dot dom. will show the days movement based on the last trade price. That is wrong, whether it's a buy or sell. Always best to base the movement on the mid.

Hope that helps.

Phil

Whilst some may think MS's purchase of 200k shares 0.7p is small. I think it will most likely signal a bottom in the share price. Remember, in addition to the major holding of his wife (KS), Mike benefited from the re pricing of share options, as a result of the TB family share sales. I obviously have no problem with that.

So what are the outstanding options/warrants?

1/11/18 David Smith (former COO) 6,017,500 @ 2.6p

20/9/22 Employee warrants 750,000 @ 2.253p

5/3/24 TB 3m, MS 8.630,474, Vinod Kaushal 6m, Brett Skelly 500k. All at 1.9p

Total options 19,680,474, total warrants 750,000.

Now, whilst TB has sold his shares to Braveheart, he has a vested interest in IBAI being successful, via his indirect holding in BRH and his direct holding options.

MS and KS are totally aligned with us. They are invested for the end game via the sale of the company. I do not see MS exercising his options any time soon. Indeed, that may only happen with an agreed sale.

For now, the question is whether other Board members will buy shares on the open market, should this be a market bottom. Quite simply, MS aside, the amount of options held is insufficient for the years spent of the Board.

Watch for further open market Board buys, whilst pi's add to their positions.

Time to be positive.

For reference, here is the Proactive interview relating to our expanded access program with GE:-

https://www.proactiveinvestors.co.uk/companies/news/1061236/iq-ai-adds-key-board-member-as-its-imaging-biometrics-subsidiary-expands-ge-partnership-1061236.html

Virtual Biopsy Market Fueled by Breakthroughs in Imaging Modalities and AI-Driven Interpretation Tools:-

https://www.newstrail.com/virtual-biopsy-market-fueled-by-breakthroughs-in-imaging-modalities-and-ai-driven-interpretation-tools/

Tyke,

Like you, I was under the impression that the FDA were going to change the PRV process, such that a voucher could not be sold unless it was part of a company sale. However, I have now come across this link, which compares CNPV to PRV.

https://www.fda.gov/news-events/press-announcements/faqs-commissioners-national-priority-voucher-program#:~:text=A4%3A%20These%20vouchers%20are%20non-transferrable.%20However%2C%20they,will%20remain%20valid%20through%20changes%20in%20company%20ownership

So is this now implying that the PRV's sale process is unchanged, or has something superseded this link?

Phil

Tyke,

Yes I agree with you.

We cannot have TB as CEO of both IB and BRH as IBAI shareholders do not have (potentially) the same opportunity as the BRH Board. Also is it right that Peterhouse are IBAI broker, when TB was a former director of them?

This is why a non exec Chairman of IBAI is needed immediately.

Phl

-- BB --,

If we get to 5p the chances are that the sp will do a multiple thereafter.

It is staggering to think that at the current offer price of 0.75p, given the progress of IB in the US and acknowledging placing dilution, the share price is circa 26x less than when at 20p.

There lies the opportunity for a predator?

Phil

Of any differences in the voting rights of (current/past) Board members/major shareholders/option holders v normal shareholders?

If we are aligned in the same way as Braveheart, MS and KS and any new Phase 2 partner is similarly aligned, then I cannot see anything other than an opportunity at the current ridiculous share price. However, it is concerning/annoying that Board members do not see the same opportunity. That said, obviously BRH/TB are very restricted in relation to purchases given their concert party holding.

With TB/family having sold to BRH at 1.1p and BRH adding in the placing at 1p, that is not suggestive of another placing sub 1p. given the need for a GM as the nominal share value is 1p.

I suspect news is coming very soon. Let us hope that the shareholding value for both KS and normal shareholders is restored to levels above 5p asap. It is high time we had a non exec Chairman appointed, who puts our interests first.

Max,

As you know, the trade value is very low. Lack of buyers mean mm's can drop the bid whilst carefully maintaining a watch on the reduced offer.

First decent buy and the offer will rise.

First big buy and much smaller buys will follow. All seeking capital gain on a quick trade.

Good news relating to revenue or confirmation of phase 2 and this will move very, very quickly.

Patience and patients needed I guess.

Phil

I see there are now 2x250k buys and 2x250k sells showing for Thursday, cancelling each other other, plus the after hours one for Thursday and the one for Friday. Both appear to be sells with a slightly different price. Maybe a rollover or two sells. Either way, I am not concerned.

Today we have two mid price 300k trades. Will we get two more to complete two rollovers?

To be honest, what we need is a 10m buy buy. Are the Board currently insiders ahead of news?

We will find out soon enough I guess.

Tyke,

The 250k sell from yesterday at 4.39pm is no longer appearing on advfn, although it is on LSE. I appreciate the trade prices are different.

Normally, a delayed trade would appear with the correct execution time and be slotted in the trade list accordingly. Had it been an auction trade, it would have been a UC trade type. Then 4.39pm would have been correct.

Phil

Yesterday's after hours sale of 250k shares is now showing as a sell from just after today's opening bell. All fun and games.

Now where are all those Director buys, assuming there is not an RNS pending, which of course there could be?

And there are numerous references to KS in the second (additional reference) link.

Summary https://www.gallixa.com/LRB/GaMForCancer.html#:~:text=1.%20Gallium%20maltolate

This contains an additional reference link https://www.gallixa.com/GaMReferences.html

Whoever it is, probably paid over in the auction so he could later drop another rounded figure. It would be amusing if it wasn't so transparent.

One thing is for sure, it won't be the Board buying. They had a shed load of options on the back of the family selling. Still, shareholders cannot grumble at the very low salaries given to directors of a Main listing Company. Oh and that isn't sarcasm.

The irony is that the newsflow should have the share price at a big multiple of the current price, right now. Sadly, greed takes hold and eventually the market doesn't forget. That said, good news will follow shortly and very probably, multiple news. Let's hope BRH are not quick sellers, unless a more supportive buyer emerges, looking to guide the company to where the great work of IB should have already taken us.

Still it's only Monday. Monday is not a great for promoting a company to potential investors seeking capital gain.

Tuesday is a great day for a 7am RNS. It better be a good one!

1,38m over three trades within a few seconds of each other. Won't be BRH and unlikely to be placees, so maybe Peterhouse selling their shares from organising the placing?

Either way, the market maker is happy to take them without, as yet, dropping the bid.

It's going to take news to interest buyers, as we do not have a Board who are interested in buying on the open market. Let's hope positive new is imminent.